Lentiviral Vector Targeting in Retinal Degeneration
Author Information
Author(s): Maritza Calame, Maité Cachafeiro, Stéphanie Philippe, Karine Schouwey, Meriem Tekaya, Dana Wanner, Chamsy Sarkis, Corinne Kostic, Yvan Arsenijevic
Primary Institution: Unit of Gene Therapy and Stem Cell Biology, Service of Ophthalmology, Jules-Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland
Hypothesis
The viral transduction would be increased by the alteration of the outer limiting membrane (OLM) during retinal degeneration.
Conclusion
Lentiviral vectors can preferentially target Müller cells in a diseased retina, which may enhance therapeutic delivery.
Supporting Evidence
- Lentiviral vectors were shown to transduce retinal cells more effectively when the outer limiting membrane was altered.
- The Mokola envelope allowed for a wider dispersion of the vector into the retina.
- Using a ubiquitous promoter improved photoreceptor transduction in degenerating retinas.
Takeaway
Researchers studied how a special virus can deliver medicine to eye cells that are sick, and found that it works better in certain types of eye damage.
Methodology
The study involved injecting lentiviral vectors into different mouse models of retinal degeneration and analyzing the transduction efficiency.
Limitations
The study primarily focused on two animal models and may not fully represent human retinal degeneration.
Participant Demographics
Mice, including light-damaged Balb-C and Rhodopsin knockout (Rho-/-) models.
Statistical Information
P-Value
0.014
Statistical Significance
p=0.014
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website